A milkshake that promises to boost the memory of Alzheimer’s patients could be available within two years.
Souvenaid is a multi-nutrient drink designed to improve cognitive function and is the result of more than ten years of research and development into the potential role of medical nutrition in neurological diseases. The first clinical trial took place between 2006 and 2008. The results of this trial,demonstrating proof of concept, are being published in the January 2010 issue of the peer-reviewed journal Alzheimer’s & Dementia.
One of the features of a brain with Alzheimer’s disease is the loss of synapses, which are junctions between two neurons or between a neuron and a muscle. Research suggests some connection between low numbers of synapses in a person’s brain and Alzheimer’s symptoms such as memory impairment and language deterioration.
Souvenaid® is a once-a-day nutritional drink designed to build nerve connections in the brain linked to memory function. Souvenaid® was shown in a clinical trial to improve memory in patients in the early stages of Alzheimer’s Disease. Souvenaid® contains Fortasyn™ Connect, a patented combination of nutrients that interact to help build brain synapses.
Source: Nutricia
